Interpretive reading of the antibiogram: A clinical necessity;Lectura interpretada del antibiograma: una necesidad clnica

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 28, Issue 6, 2010, Pages 375-385

  Cantn, Rafael ^a  

^a Hospital Ramn y Cajal   (Spain)

Author keywords

Interpretive reading; Resistance mechanisms; Resistance phenotype

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; CORRELATION ANALYSIS; DNA MODIFICATION; LABORATORY DIAGNOSIS; MEDICAL SPECIALIST; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGICAL PARAMETERS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; QUALITY CONTROL; REVIEW; VALIDATION PROCESS;

EID: 77953872991     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2010.01.001     Document Type: Article

References (97)

1. R. Cantn Lectura interpretada del antibiograma: ¿ejercicio intelectual o necesidad clnica? Enferm Infecc Microbiol Clin 20 2002 176 185
2. G. Cornaglia, W. Hryniewicz, V. Jarlier, G. Kahlmeter, H. Mittermayer, and L. Stratchounski European recommendations for antimicrobial resistance surveillance Clin Microbiol Infect 10 2004 349 383
3. R. Cantn, and J. Cobo Consumo de antimicrobianos y resistencia en el hospital: una relacin difcil de medir y compleja de interpretar Enferm Infecc Microbiol Clin 27 2009 437 440
4. P.G. Ambrose Monte Carlo simulation in the evaluation of susceptibility breakpoints: Predicting the future: Insights from the Society of Infectious Diseases Pharmacists Pharmacotherapy 26 2006 129 134
5. J. Turnidge, and D.L. Paterson Setting and revising antibacterial susceptibility breakpoints Clin Microbiol Revs 20 2007 391 408
6. G. Kahlmeter, D.F.J. Brown, F.W. Goldstein, A.P. MacGowan, J.W. Mouton, and A. Sterland European harmonisation of MIC breakpoints for antimicrobial susceptibility testing of bacteria J Antimicrob Chemother 52 2003 145 148
7. J.H. Jorgensen, and M.J. Ferraro Antimicrobial susceptibility testing: A review of general principles and contemporary practices Clinical Infectious Diseases 49 2009 1749 1755
8. European Committe for Antimicrobial Susceptibility Testing. [consultado 20/12/2010]. Disponible en: URL: http://www.eucast.org
9. J. Van Eldere Changing needs, opportunities and constraints for the 21st century microbiology laboratory Clin Microbiol Infect 11 Suppl 1 2005 15 18
10. J.A. Poupard, S.F. Rittenhouse, and L.R. Walsh The evolution of antimicrobial susceptibility testing methods J.A. Poupard, L.R. Walsj, B. Kleger, Antimicrobial susceptibility testing 1994 Plenum Press New York, NY 3 14
11. Mesa Espaola de Normalizacin de la Sensibilidad y Resistencia a los Antimicrobianos. (MENSURA). Recomendaciones del grupo MENSURA para la seleccin de antimicrobianos en el estudio de la sensibilidad y criterios de interpretacin del antibiograma Rev Esp Quimioter 13 2000 73 86
12. M.J. Ferraro Should we reevaluate antibiotic breakpoints? Clin Infect Dis 33 2001 S240 S244
13. Comit de l'Antibiogramme de la Socit Franaise de Microbiologie. Recomendations 2009. 2009 [consultado 20/12/2010]. Disponible en: http://www.sfm.asso.fr www.sfm.asso.fr
14. Working Party of the British Society for Antimicrobial Chemotherapy Antimicrobial susceptibility testing: BSAC Working Party Report J Antimicrob Chemother 48 2001
15. F. Baquero European standards for antibiotic susceptibility testing: Towards a theoretical consensus Eur J Clin Microbiol Infect Dis 9 1990 492 495
16. International Organization for Standardization (ISO). 2006 Clinical laboratory testing and in vitro diagnostic diagnostic test systems Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices-Part 1: Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases.International Standard 20776-1, ISO, Ginebra.
17. J. Turnidge, G. Kahlmeter, and G. Kronvall Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values Clin Microbiol Infect 12 2006 418 425
18. P. Courvalin Interpretive reading of antimicrobial susceptibility test ASM News 58 1992 368 375
19. D.M. Livermore, T.G. Winstanley, and K.P. Shannon Interpretative reading: Recognizing the unusual and inferring resistance mechanisms from resistance phenotypes J Antimicrob Chemother 48 Suppl 1 2001 87 102
20. R. Cantn Role of the microbiology laboratory in infectious disease surveillance, alert and response Clin Microbiol Infect 11 2005 3 8
21. F. Baquero, R. Cantn, and G. Cornaglia Public-health microbiology, a challenge for Europe Clin Microbiol Infect 2010 16:123-5
22. A.A. Medeiros, R.L. Kent, and T.F. O'Brien Characterization and prevalence of the different mechanisms of resistance to β-lactam antibiotics in clinical isolates of Escherichia coli Antimicrob Agents Chemother 6 1974 791 801
23. E. Loza Fernndez de Bobadilla, and J. Martnez-Beltrn Evolucin de la actividad de cefotaxima en 6 aos y fenotipos de sensibilidad en Enterobacteriaceae Enf Infec Microbiol Clin 6 1988 3 13
24. P.M. Shah, and W. Stille Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than third generation cephalosporins J Antimicrob Chemother 11 1983 597 601
25. H.F. Chambers, M. Sachdeva, and S. Kennedy Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus J Infect Dis 162 1990 705 710
26. M.G. Page Anti-MRSA beta-lactams in development Curr Opin Pharmacol 5 2006 480 485
27. R. Davidson, R. Cavalcanti, J.L. Brunton, D.J. Bast, J.C. De Azavedo, and P. Kibsey Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia N Engl J Med 346 2002 747 750
28. M. Helms, P. Vastrup, P. Gerner-Smidt, and K. Molbak Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium Emerg Infect Dis 8 2002 490 495
29. R. Slinger, M. Desjardins, A.E. McCarthy, K. Ramotar, P. Jessamine, and C. Guibord Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: A case series BMC Infect Dis 4 2004 36
30. T. Kadhiravan, N. Wig, A. Kapil, S.K. Kabra, K. Renuka, and A. Misra Clinical outcomes in typhoid fever: Adverse impact of infection with nalidixic acid-resistant Salmonella typhi BMC Infect Dis 5 2005 37
31. A. Martel, N. Moreau, M.L. Capmau, C.J. Soussy, and J. Duval 2"-O-phosphorylation of gentamicin components by a Staphylococcus aureus strain carrying a plasmid Antimicrob Agents Chemother 12 1977 26 30
32. N. Asseray, J. Caillon, N. Roux, C. Jacqueline, R. Bismuth, and M.F. Kergueris Different aminoglycoside-resistant phenotypes in a rabbit Staphylococcus aureus endocarditis infection model Antimicrob Agents Chemother 46 2002 1591 1593
33. Clinical and Laboratory Standards Institute. Performance and standards for antimicrobial susceptibility testing. Nineteen informational supplement. Document M100-S20. 2010. Wayne, PA.
34. D. Andes, and W.A. Craig Treatment of infections with ESBL-producing organisms: Pharmacokinetic and pharmacodynamic considerations Clin Microbiol Infect 11 2005 10 17
35. C. Bin, W. Hui, Z. Renyuan, N. Yongzhong, X. Xiuli, and X. Yingchun Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli Diagn Microbiol Infect Dis 56 2006 351 357
36. S.V. Bhat, A.Y. Peleg, T.P. Lodise Jr, K.A. Shutt, B. Capitano, and B.A. Potoski Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by gram-negative organisms Antimicrob Agents Chemother 51 2007 4390 4395
37. P. Courvalin Interpretive reading of in vitro antibiotic susceptibility tests (the antibiogramme) Clin Microbiol Infect 2 1996 S26 S34
38. A.P. Macgowan BSAC working parties on resistance surveillance. Clinical implications of antimicrobial resistance for therapy J Antimicrob Chemother 62 2008 ii105 ii114
39. P.A. Moise-Broder, G. Sakoulas, G.M. Eliopoulos, J.J. Schentag, A. Forrest, and R.C. Moellering Jr Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy Clin Infect Dis 38 2004 1700 1705
40. A. Soriano, F. Marco, J.A. Martnez, E. Pisos, M. Almela, and V.P. Dimova Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia Clin Infect Dis 46 2008 193 200 (Pubitemid 351269157)
41. A.C. Musta, K. Riederer, S. Shemes, P. Chase, J. Jose, and L.B. Johnson Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: Trends over 11 years J Clin Microbiol 47 2009 1640 1644
42. F.M. Aarestrup, C. Wiuff, K. Mølbak, and E.J. Threlfall Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob Agents Chemother 47 2003 827 829
43. J.A. Crump, K. Kretsinger, K. Gay, R.M. Hoeckstra, D.J. Vugia, and S. Hurd Clinical response and outcome of infection with Salmonella enterica serotype typhi with decreased susceptibility to fluoroquinolones: A United States foodnet multicenter retrospective cohort study Antimicrob Agents Chemother 52 2008 1278 1284
44. F. Navarro, E. Mir, and B. Mirelis Lectura interpretada del antibiograma en enterobacterias Enf Infec Microbiol Clin 20 2002 225 234
45. Davis SL, Neuhauser MM, McKinnon PS. Quinolones. En: Yu VL, Edwards G, MaKinnon PS, Peloquin C, Morse GD, editores. Antimicrobial therapy and vaccines. 2 ed. Pittsburgh, PA (EEUU): 2005. pp. 33766.
46. V. Cattoir, and P. Nordmann Plasmid-mediated quinolone resistance in gram-negative bacterial species: An update Curr Med Chem 16 2009 1028 1046
47. L. Poirel, J.D. Pitout, L. Calvo, J.M. Rodrguez-Martnez, D. Church, and P. Nordmann In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum beta-lactamase Antimicrob Agents Chemother 50 2006 1525 1527
48. L. Poirel, V. Cattoir, and P. Nordmann Is plasmid-mediated quinolone resistance a clinically significant problem? Clin Microbiol Infect 14 2008 295 297
49. B. Murray Vancomycin-resistant enterococcal infections N Engl J Med 342 2000 710 721
50. B. Weisblum Macrolide resistance Drug Res Updates 1 1998 29 41
51. G. Cornaglia, K. Russell, G. Satta, and R. Fontana Relative importances of outer membrane permeability and group 1 β-lactamase as determinants of meropenem and imipenem activities against Enterobacter cloacae Antimicrob Agents Chemother 39 1995 350 355
52. R.N. Jones, J.E. Ross, J.M. Bell, U. Utsuki, I. Fumiaki, and I. Kobayashi Zyvox Annual Appraisal of Potency and Spectrum program: Linezolid surveillance program results for 2008 Diagn Microbiol Infect Dis 65 2009 404 413
53. K.S. Long, J. Poehlsgaard, C. Kehrenberg, S. Schwarz, and B. Vester The Cfr rRNA methyltransferase confers resistance to Phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics Antimicrob Agents Chemother 50 2006 2500 2505
54. M. Tato, T.M. Coque, P. Ruz-Garbajosa, V. Pintado, J. Cobo, and H.S. Sader Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: Toward endemicity? Clin Infect Dis 45 2007 1171 1178
55. A. Vatopoulos High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece-a review of the current evidence Euro Surveill 24 2008 13
56. P.C. Appelbaum Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA) Int J Antimicrob Agents 30 2007 398 408
57. D.M. Livermore, M. Struelens, J. Amorin, F. Baquero, J. Bille, and R. Cantn Multicenter evaluation of the VITEK 2 Advance Expert System for interpretive reading of antimicrobial resistance tests J Antimicrobial Chemother 49 2002 289 300
58. R. Cantn, I. Als, F. Baquero, J. Calvo, J. Campos, and J. Castillo Recomendaciones para la seleccin de antimicrobianos y concentraciones en el estudio de la sensibilidad in vitro con sistemas automticos y semiautomticos Enferm Infecc Microbiol Clin 25 2007 394 400
59. M.L. Wilson Assuring the quality of clinical microbiology test results Clin Infect Dis 47 2008 1077 1082
60. D.M. Livermore β-lactamases in laboratory and clinical resistance Clin Microbiol Rev 8 1995 557 584
61. G.H. Miller, F.J. Sabatelli, R.S. Hare, Y. Glupczynski, P. Mackay, and D. Shlaes The most frequent aminoglycoside resistance mechanisms changes with time and geographic area-a reflection of aminoglycoside usage patterns? Clin Infect Dis 24 1997 S46 S62
62. K. Poole Multidrug resistance in gram-negative bacteria Curr Opin Microbiol 4 2001 500 508
63. D.C. Hooper Mechanisms of action and resistance of older and newer fluoroquinolones Clin Infect Dis 31 2000 S24 S28
64. F.J. Schmitz, A.C. Fluit, M. Gondolf, R. Beyrau, E. Lindenlauf, and J. Verhoef The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals J Antimicrob Chemother 43 1999 253 259
65. C. Torres Lectura interpretada del antibiograma de cocos grampositivos Enferm Infecc Microbiol Clin 20 2002 354 364
66. V. Jarlier, M.H. Nicolas, G. Fournier, and A. Philippon Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns Rev Infect Dis 10 1988 867 878
67. R. Edwards, C.V. Hawkyard, and P.S. Hashmi Biological assay for the detection of metallo-β-lactamases in Bacteroides fragilis Br J Biomed Sci 55 1998 169 171
68. A. Tsakris, A. Poulou, K. Themeli-Digalaki, E. Voulgari, T. Pittaras, and D. Sofianou Use of boronic acid disk tests to detect extended-spectrum beta-lactamases in clinical isolates of KPC carbapenemase-possessing enterobacteriaceae J Clin Microbiol 47 2009 3420 3426
69. K.S. Shin, B.R. Son, S.B. Hong, and J. Kim Dipicolinic acid-based disk methods for detection of metallo-beta-lactamase-producing Pseudomonas spp. and Acinetobacter spp. Diagn Microbiol Infect Dis 62 2008 102 105
70. T.Y. Tan, L.S. Ng, J. He, T.H. Koh, and L.Y. Hsu Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis Antimicrob Agents Chemother 53 2009 146 149
71. A. Ribera, J. Ruiz, M.T. Jiminez de Anta, and J. Vila Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates J Antimicrob Chemother 49 2002 697 698
72. G.W. Kaatz, V.V. Moudgal, and S.M. Seo Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus J Antimicrob Chemother 50 2002 833 838
73. F. Baquero Low-level antibacterial resistance: A gateway to clinical resistance Drug Res Updates 4 2001 93 105
74. P. Nordmann, G. Cuzon, and T. Naas The real threat of Klebsiella pneumoniae carbapenemase producing bacteria Lancet Infect Dis 9 2009 228 236
75. F.C. Tenover VRSA, VISA, and GISA: The dilema behind the name game Clin Microbiol Newletter 22 2000 49 53
76. D.I. Hsu, L.K. Hidayat, R. Quist, J. Hindler, A. Karlsson, and A. Yusof Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections Int J Antimicrob Agents 32 2008 378 385
77. A. Novais, R. Cantn, T.M. Coque, A. Moya, F. Baquero, and J.C. Galn Mutational events in cefotaximase extended-spectrum beta-lactamases of the CTX-M-1 cluster involved in ceftazidime resistance Antimicrob Agents Chemother 52 2008 2377 2382
78. D. Sham The role of clinical microbiology in the control and surveillance of antimicrobial resistance ASM News 62 1996 25 29
79. H.F. Chambers The changing epidemiology of Staphylococcus aureus? Emerging Infect Dis 7 2001 178 182
80. R. Cantn, and T.M. Coque The CTX-M beta-lactamase pandemic Curr Opin Microbiol 9 2006 466 475
81. T.M. Coque, A. Oliver, J.C. Prez-Daz, F. Baquero, and R. Cantn Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum-β-lactamases are carried by multiple Klebsiella pneumoniae clones in a single Hospital (Madrid, 1989 to 2000) Antimicrob Agents Chemother 46 2002 500 510
82. P. Ruiz-Garbajosa, R. Del Campo, T.M. Coque, A. Asensio, M. Bonten, and R. Willems Longer intestinal persistence of Enterococcus faecalis compared to Enterococcus faecium clones in intensive-care-unit patients J Clin Microbiol 47 2009 345 351
83. F.F. Barret, R.F. McGehee, and M. Finland Methicillin-resistant Staphylococcus aureus at Boston City Hospital: Bacteriologic and epidemiology observations N Engl J Med 279 1968 441 448
84. K. Kaye, S. Cosgrove, A. Harris, G.M. Eliopoulos, and Y. Carmeli Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp. Antimicrobial Agents Chemother 45 2001 2628 2630
85. M. Kawalec, M. Gniadkowski, J. Kedzierska, A. Skotnicki, J. Fiett, and W. Hryniewicz Selection of a teicoplanin-resistant Enterococcus faecium mutant during an outbreak caused by vancomycin-resistant enterococci with the VanB phenotype J Clin Microbiol 39 2001 4274 4282
86. M.H. Kollef Is there a role for antibiotic cycling in the intensive care unit? Crit Care Med 29 2001 N135 N142
87. D.N. Gerding Antimicrobial cycling: Lessons learned from aminoglycoside experience Infect Control Hosp Epidemiol 21 2000 S12 S17
88. C. Urban, N. Mariano, N. Rahman, A. Queena, D. Montenegro, and K. Bush Detection of multirresistant ceftazidime-susceptible Klebsiella pneumoniae isolates lacking TEM-26 after class restriction of cephalosporins Microb Drug Resist 6 2000 297 303
89. F. Baquero, T.M. Coque, and R. Cantn Antibiotics, complexity, and evolution ASM News 69 2003 547 552
90. Y. Sun, Z. Zeng, S. Chen, J. Ma, L. He, and Y. Liu High prevalence of bla extended-spectrum beta(CTX-M)-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China Clin Microbiol Infect 2009 [Epub ahead of print]
91. L. Drieux, F. Brossier, W. Sougakoff, and V. Jarlier Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: Review and bench guide Clin Microbiol Infect 14 2008 90 103
92. G. Lina, A. Quaglia, M.E. Reverdy, R. Leclercq, F. Vandenesch, and J. Etienne Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci Antimicrob Agents Chemother 43 1999 1062 1066 (Pubitemid 29214725)
93. E.G. De la Pedrosa, M.I. Morosini, M. Van der Linden, P. Ruiz-Garbajosa, J.C. Galn, and F. Baquero Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B) Antimicrob Agents Chemother 52 2008 1964 1969
94. S. Navon-Venezia, R. Ben-Ami, and Y. Carmeli Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting Curr Opin Infect Dis 18 2005 306 313
95. S. Aksaray, B. DokuzoGuz, E. Guvener, M. Yucesoy, N. Yulug, and S. Kocagoz Surveillance of antimicrobial resistance among gram-negative isolates from intensive care units in eight hospitals in Turkey J Antimicrob Chemother 45 2000 695 699 (Pubitemid 30255654)
96. N. Woodford, J.W. Dallow, R.L. Hill, M.F. Palepou, R. Pike, and M.E. Ward Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory Int J Antimicrob Agents 29 2007 456 459
97. T.R. Walsh Clinically significant carbapenemases: An update Curr Opin InfectDis 21 2008 367 371